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Accepted 10 February 2016Themanagement of older persons with cancer has become amajor public health concern in
developed countries because of the aging of the population and the steady increase in
cancer incidence with advancing age. Nurses and allied health care professionals are
challenged to address the needs of this growing population. The International Society of
Geriatric Oncology (SIOG) Nursing and Allied Health (NAH) Interest Group described key
issues that nurses and allied health care professionals face when caring for older persons
with cancer. The domains of the Geriatric Assessment (GA) are used as a guiding
framework. The following geriatric domains are described: demographic data and social
support, functional status, cognition, mental health, nutritional status, fatigue,
comorbidities, polypharmacy, and other geriatric syndromes (e.g. falls, delirium). In
addition to these geriatric domains, quality of life (QoL) is described based on the overall
importance in this particular population. Advice for integration of assessment of these
geriatric domains into daily oncology practice is made. Research has mainly focused on the
role of treating physicians but the involvement of nurses and allied health care
professionals is crucial in the care of older persons with cancer through the GA process.
The ability of nurses and allied health care professionals to perform this assessment
requires specialized training and education beyond standard oncology knowledge.
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Worldwide cancer occurs more commonly in older persons.1
The Institute of Medicine (IOM) noted a gap in the educational
preparation of health care professionals to care for this aging
population and called on the health care community to develop
innovative ways to improve care for older patients.2 Nurses and
allied health care professionals play a key role in caring for older
patients with cancer both hospitalized and ambulatory patients,
since the latter is of increasing importance in daily oncology
practice. Globally they can develop an awareness of the special
needsof older patients, gain education in the science of geriatrics,
and provide age-sensitive care to optimize care of the older
patient with cancer.
The International Society of Geriatric Oncology (SIOG)
Nursing and Allied Health (NAH) Interest Group identified a
need to share state of the art knowledge with other nurses
and allied health care professionals about the special needs of
caring for older patients with cancer. To describe these special
needs, Comprehensive Geriatric Assessment (CGA) is rec-
ommended. CGA is defined as a ‘multidimensional, interdis-
ciplinary diagnostic process focusing on determining an
older person's medical, psychosocial and functional capabil-
ity in order to develop a coordinated and integrated plan forPlease cite this article as: Burhenn PS., et al, Geriatric assessmen
professionals: Opinion paper of the Nursing and ..., J Geriatr Oncol (treatment and long-term follow-up’.3 In summary, this method
comprises five consecutive steps and is the main principle of
modern geriatric medicine4: identifying patients who can benefit
from CGA; assessing these patients; developing recommenda-
tions for geriatric interventions based on the detected problems
by CGA; implementing these recommendations in a care plan;
and provision of follow-up and adjustment of the care plan with
repeated CGA. Because CGA research specifically in oncology has
mainly studied the steps of geriatric screening and assessment,
the term geriatric assessment (GA) is recommended rather than
CGA.5
In the past decade guidelines for Geriatric Assessment (GA)
have been developed under auspices of SIOG.5,6 The current
guideline defines the geriatric domains to consider when
caring for older adults with cancer: demographic data and
social support, functional status, cognition, mental health,
nutritional status, fatigue, comorbidities, polypharmacy, and
other geriatric syndromes (e.g. delirium, falls).5 In addition to
these geriatric domains, quality of life (QoL) is described due
to its significance to nursing and patient outcomes.7
The aim of this opinion paper is to outline the key domains of
the GA and QoL for nurses and allied health care professionals
when caring for older patients with cancer and to address
practical advice.t in daily oncology practice for nurses and allied health care
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Older Adult with Cancer
It is widely understood that older persons all over the world
are among the most sociodemographically challenged in
termsof income, health literacy, andaccess tohealth care.8 Social
isolation and disadvantage are considered independent
predictors of mortality in the older population with cancer
because adequate social support provides a buffer against
the stress inherent in the illness.9 It is therefore important to
assess the psychosocial variables that might usefully inform
treatment decision-making, such as the presence and adequacy
of a caregiver, living conditions, level of income, and access to
transportation.10
2.1. Advice for Nurses and Allied Health Care Professionals
Demographics and social support data can be derived from
self-report of the older patient or can be collected from the
patient chart. The choice of instrument to assess the patient's
level of social support will depend on the precise context of
practice and the human and material resources available.
There are notmany instruments available for this purpose but
one of the more commonly used is the Medical Outcomes
Social Support Survey (MOS-SS) which is used in the geriatric
oncology setting.11 Any concerns identified by the informa-
tion reported by the older patient or by the instrument can
trigger a referral to the social worker or relevant community
support service.3. Comorbidities and the Older Adult with Cancer
As the population ages, the prevalence of patients with cancer
and comorbidities will increase.12 On average, older adults
suffer from three comorbidities and those with cancer are
likely to suffer from more. Registry studies report that 40% or
more of older patients with cancer suffer from four or more
comorbidities.13 Not only cancer survival but also cancer
treatment is impacted by comorbidities. Older patients with
cancer and comorbidities are less likely to receive cancer
treatment, less likely to tolerate side effects, and are less
likely to complete therapy.12
3.1. Advice for Nurses and Allied Health Care Professionals
Acomprehensive healthhistory to assess comorbidities is vital to
the care of the older patient with cancer and is evaluated before,
during and after cancer treatment. The comorbidities of the
patient can be obtained during the initial visit when the
history and physical are conducted.13 They are also collected
as part of the GA, however, the health care team member
that collects this information may vary by country. The use
of validated comorbidity scales, such as the Charlson Comorbid-
ity Index (CCI)14 or the Cumulative Illness Rating Scale for
Geriatrics (CIRS-G),15 can be incorporated into the GA. These
scales can be useful in predicting outcomes in older patients
with cancer.16 It is advisable that comorbidities also are examined
individually as certain conditions may have a greater impact onPlease cite this article as: Burhenn PS., et al, Geriatric assessmen
professionals: Opinion paper of the Nursing and ..., J Geriatr Oncol (cancer treatment outcomes than others.17 Collaborationwith the
patient's primary care provider and sharing the plan of care and
treatment summary is a best practice to integrate the manage-
ment of cancer care and comorbidities.4. Functional Status and the Older Adult
with Cancer
Maintenance of functional status is a key issue for older
persons, certainly for those diagnosed with cancer. Func-
tional impairment has been independently associated with
increased comorbidities18 and shorter survival19 and can lead to
higher dependency, institutionalization, and decreased
QoL.19,20 Repeated assessment of functional status over time
gives health care professionals in general the opportunity to
identify functional decline, which is a major threat for older
persons in general21with increased risk forhospital andnursing
home admission and mortality.22–24 The possibility to predict
functional decline is crucial as it could allow preventive
measures for patients at risk.4,25,26
4.1. Advice for Nurses and Allied Health Care Professionals
Tools such as Karnofsky27 or Eastern Cooperative Oncology
group Performance Status (ECOG-PS)28 scales reflect function-
al status in a very simplistic way, and were not specifically
developed and validated in the older population. More
sophisticated and age-adapted tools used in geriatric medi-
cine are Katz's Activities of Daily Living (ADL) scale29 and
Lawton's Instrumental Activities of Daily Living (IADL) scale.30
Both tools are commonly used in the older population with
cancer.5,31 In case of functional impairments, targeted inter-
ventions (e.g. structured exercise, mobilization training,
progressive resistance strength training, rehabilitation thera-
py) should be established in collaboration with occupational
therapists or physical therapists. Follow-up needs are inte-
grated within the care plan of the older patient to prevent
functional decline.5. Cognition and the Older Adult with Cancer
Older persons may experience cognitive declines as they age
ranging frommild cognitive impairment (MCI) to dementia.32
Cognitive changes can impact QoL and result in functional
decline.33,34 Prior to cancer treatment, cognitive evaluation
can be performed. Depression and cognitive impairment are
known as risk factors for developing delirium.35 Therefore it is
important to monitor for cognitive changes in the older
population with cancer to determine risk for other syndromes.
5.1. Advice for Nurses and Allied Health Care Professionals
Cognitive impairment can be assessed using a variety of
validated tools. A simple measure of cognition can be performed
using the Mini-COG34,36 or other tools mentioned in the SIOG
guideline for GA.5 A patient who has cognitive impairment is
assessed for decision making capacity by the treating physician
to ensure understanding of care options, the rationale for thet in daily oncology practice for nurses and allied health care
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ability to communicate their choice.34,38 The results of cognition
screening and any identified abnormalities should be considered
when recommending treatment options. For example, a patient
with MCI who is responsible for independent medication
management would need support going home with an oral
anticancer agent. Patients with positive screens for cognitive
problems should be referred to a neurologist, psychiatrist, or
geriatrician as appropriate.386. Depression and the Older Adult with Cancer
Depression, ranging from the distressed mood that is a natural
reaction to a distressing diagnosis to entrenched endogenous
depression is common in the general older population (3–30%).39
It has been documented in up to 22% of patients with cancer.40
While it can be as common in older patientswith cancer as it is in
younger individuals, and as likely to lead to adverse treatment
outcomes,40 depression in older persons requires a geriatric
specific assessment. Aspects of depression that warrant assess-
ment include cognitive symptoms, memory, optimism, self-
image, loss, anxiety, obsessive traits and mood swings.41
6.1. Advice for Nurses and Allied Health Care Professionals
While no instrument is considered completely reliable and
valid to evaluate depression in the older patient with cancer,
the Geriatric Depression Scale (GDS),42 or similar provides a
useful screen for risk of depression. This can then be followed
up with a referral for a comprehensive psychological assess-
ment, a referral to the psychosocial oncology program which
is existing in most cancer centers, or even a referral to a
support group or social worker where appropriate.7. Nutrition and the Older Adult with Cancer
Malnutrition in older patients with cancer is considered a
prognostic indicator of morbidity and mortality43 and is very
common in the older population with cancer. In particular,
unintentional weight loss in the 6 months prior to chemo-
therapy is associated with poorer survival and lower chemo-
therapy response rates10; while low body mass index (BMI) is
associated with increased dependence in ADL and decreased
1-year survival.9 Body mass index (BMI) is a frequently-used
measure of nutritional status and is routinely calculated in
cancer settings to determine chemotherapy dose. However,
BMI is probably not the most accurate indicator of nutritional
status and potential outcomes in this context. Loss of height
due to aging is often unaccounted for in these calculations
and as such, BMI is often overestimated.44 Also, BMI does not
distinguish lean body mass from fat mass or skeletal muscle
mass, which are more reliable indicators of nutritional risk.45
7.1. Advice for Nurses and Allied Health Care Professionals
BMI in isolation should be used cautiously to judge nutritional
status and treatment outcomes in older persons. Where BMI is
the only indicator available, the age-adjusted recommendedPlease cite this article as: Burhenn PS., et al, Geriatric assessmen
professionals: Opinion paper of the Nursing and ..., J Geriatr Oncol (cut-offs should be taken into account for definingmalnutrition or
a risk for malnutrition.46 Malnutrition screening tools, such as
theMalnutrition Screening Tool for Cancer Patients (MSTC)47 and
Mini Nutritional Assessment (MNA),48 detect those at risk
irrespective of BMI. It is advisable as a useful screen for
malnutrition, which triggers a subsequent dietitian referral
and more comprehensive dietetic assessment. In addition,
unintentional weight loss, which is often incorporated in
malnutrition screening tools, can be questioned as an easy
stand-alone nutritional parameter. More specific, biochemical
assessment of serum albumin,49 vitamin D50and B1251 levels is
recommended for their relevance in the older population (e.g.
related to falls, memory problems). Nurses and allied health care
professionals can pay additional attention to protein and calorie
intake of the older patient with cancer.8. Fatigue and the Older Adult with Cancer
Cancer-related fatigue (CRF) is a common debilitating symp-
tom, with a prevalence that reaches 70% in older patients with
cancer throughout the course of disease and treatment.52
Clinically, CRF is characterized as an unusual sense of
tiredness that does not relieve with adequate rest, and is
disproportionate to the level of physical exertion and with
concomitant daytime dysfunction.53 Although the underling
mechanisms of CRF is not fully understood, it has been suggested
to be related to complex neuroendocrine and biobehavioral
mechanisms, and an interaction ofmetabolic, somatic, emotion-
al, cognitive, and psychosocial factors associatedwith cancer and
its treatment.54,55 Accumulating evidence has shown that CRF
often co-occurs with pain, mood, and sleep disturbance, and is
associated with cognitive impairment. These symptoms may
have similar patterns over time, and can have synergistic effects
on multiple dimensions of the QoL of older patients with
cancer.56–58
8.1. Advice for Nurses and Allied Health Care Professionals
It is important for nurses and allied health care professionals
to understand CRF and its mechanisms and full impact in the
context of symptom cluster and aging. Continuous and com-
prehensive assessment of CRF and other contributing factors,
as well as provision of strategies and resources useful in
coping with CRF, is equally important. A number of instru-
ments have been developed to measure CRF, including the
Functional Assessment of Cancer Therapy: Fatigue (FACT-F)
scale,59 the EORTC QLQ C30 Fatigue subscale,60 or a simple
Visual Analogue Scale (VAS),61 and they are the most
commonly used instruments across different cancer settings.
Increasing evidence suggests that energy conservation, dis-
traction techniques, exercise/physical activity, and cognitive
behavioral therapies initiated by nurses and allied health care
professionals could be effective in reducing CRF.62,63 Energy
conservation may include prioritization of daily activities to
prevent energy depletion, and distraction techniques may
include reading and socializing to help take mind off from
fatigue. Exercise/physical activity and cognitive behavioral
therapies may include moderate exercise program to improve
functional capacity and psychosocial program to managet in daily oncology practice for nurses and allied health care
2016), http://dx.doi.org/10.1016/j.jgo.2016.02.006
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nutritional statuses, and frailty should be made in older
population with cancer.9. Polypharmacy and Medication Related Problems
in the Older Adult with Cancer
A comprehensive medication assessment (e.g. prescription,
non-prescription and complementary and alternative medi-
cines and supplements) is an integral part of the geriatric
oncology assessment. The National Comprehensive Cancer
Network (NCCN) Older Adult Oncology Guidelines recommend
a thorough evaluation for polypharmacy, potentially inappropri-
ate medications (PIM) with subsequent discontinuation of any
nonessential or high-risk medications.38 Cancer-related therapy
adds to the prevalence of multiple medication use and/or inap-
propriate medication consumption because new medications
escalate pill burden and medication regimen complexity. As a
consequence, there is an increased risk for adverse drug effects,
drug-drug interactions, and increased risk for non-adherence.
Polypharmacy is commonly defined as concurrent use of five or
more medications, including prescription, non-prescription and
complementary / herbal supplements64–66 or by the prescribing of
PIMwhichmay increase the risk for adverse drug effects in older
adults. Potentially inappropriatemedicationsmay be categorized
based on screening tools such as the updated Beers criteria, the
Screening Tool of Older Person's Prescriptions (STOPP) criteria
and the Medication Appropriateness Index (MAI).67–74 Existing
studies that report on the prevalence of polypharmacy and PIM
use, specifically in ambulatory older adults with cancer, report
the prevalence of polypharmacy as high as 84% and PIM use as
high as 51%.75–79 The consequences of polypharmacy and PIM
warrant substantial interest and concern because of the perils
associated with their use in this vulnerable population; vulner-
abilities include increased risk of falls and/or fractures, cognitive
impairment, and delirium, all of which can lead to compromised
cancer management plans.
9.1. Advice for Nurses and Allied Health Care Professionals
Medication reconciliation and rational discontinuation of
non-essential and high-risk medications are critical compo-
nents of medication management. The brown bag method is
recommended and involves the patient bringing all medicines
into the clinic for a provider to review. In addition, the
clinician can assess patients' ability to read medication label
directions, self-administer and manage medications in an
organized manner. Currently, there is not a consensus or
specific guideline on the management of polypharmacy or
PIM in older adults with cancer. Interventions involving
comprehensive medication management services in geriatric
ambulatory and long term care facilities have shown a
reduction in ineffective and unnecessary medications.66,80–82
Additionally, adherence of the patient to use their medication
properly is a particular point of interest for nurses and allied
health care professionals,83 however, there is an existing gap
in the literature regarding effective/validated tools to measure
medication adherence and optimal interventions to improve
adherence in the setting polypharmacy.Please cite this article as: Burhenn PS., et al, Geriatric assessmen
professionals: Opinion paper of the Nursing and ..., J Geriatr Oncol (10. Geriatric Syndromes in General and the Older
Adult with Cancer
Older persons are susceptible to certain conditions that have
been termed geriatric syndromes. These are health-related
conditions that do not follow a specific diagnosis, are
prevalent especially in frail, older persons, and can lead to
poor outcomes including disability and altered QoL.84 There
is no one definition of what constitutes a geriatric syndrome.
The current SIOG GA guideline outlined them as: dementia,
delirium, incontinence, osteoporosis, neglect or abuse, failure to
thrive, falls, constipation, polypharmacy, pressure ulcers,
and sarcopenia.5
10.1. Advice for Nurses and Allied Health Care Professionals
The Fulmer SPICES assessment tool has been used to uncover
common syndromes and evaluates for evidence of sleep
disorders, problems with eating or feeding, incontinence,
confusion, evidence of falls, and skin breakdown.85 In 2007
Inouye, et al conducted a systematic review of geriatric syn-
dromes and risk factors, they investigated five: pressure ulcers,
incontinence, falls, functional decline, and delirium.84 The
Hartford Institute of Nursing website (www.hartfordign.org) has
multiple assessment tools for each syndrome identified.86
Because many of these syndromes are multi-factorial and not
specifically related to a diagnosis they may be overlooked by the
clinician attending to a specific diagnosis. The nurse or allied
health care professional can serve as a key observer for geriatric
syndromes and assess using one of the suggested tools or
guideline. Positive screens will require further workup by
specialists in these areas, for example, a patient experienc-
ing incontinence can be referred to urology for interventions
which may include bladder training or appropriate devices
and exercises. A positive screen for poor sleep can lead to a
discussion by the nurse of non-pharmacological methods to
induce sleep.11. Geriatric Syndrome: Delirium and the Older
Adult with Cancer
Patients with cognitive impairments are at a higher risk for
delirium,87 especially during and after cancer treatment and
when the older patient is hospitalized. Delirium incidence has
been reduced inmedical and surgical wards with the implemen-
tation of a delirium prevention protocol.88,89 Although these
studies were not in cancer populations the interventions
involvemeeting basic care needs, such as hydration, orientation,
and mobility. These interventions could be initiated in an
oncology setting.
11.1. Advice for Nurses and Allied Health Care Professionals
Delirium screening can be done using a screening tool such
as the Confusion Assessment Method (CAM),90 Memorial
Delirium Assessment Scale (MDAS),91 or the Delirium Rating
Scale-Revised 98 (DRS-R-98),92 all of which have been validated
in an oncology setting.93t in daily oncology practice for nurses and allied health care
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with Cancer
Falls are a common problem in the general older population
and the older population with cancer.94 One third of older
adults fall annually and up to half of these patients will
experience recurrent falls.95,96 Falls represent a major cause
of morbidity, mortality, and functional decline.95,97 The
etiology of a fall is often multi-factorial due to a combination
of physiological age-related changes, pathological elements
and behavioral or environmental factors.98,99 Therefore,
identification of strong fall predictors is essential in the
planning of preventive measures. Recently, the history of a
fall in the year before cancer treatment was identified as a
main predictor of falls occurring after cancer treatment.94
12.1. Advice for Nurses and Allied Health Care Professionals
Preventive measures, in high fall risk patients according to
identified fall predictors, can be tailored to an individual patient
by considering those factors that contributed to the high fall risk.
According to fall risk assessment and the implementation of
preventive measures, several guidelines have been developed
such as the American Geriatrics Society (AGS) ‘Prevention of falls
in older persons’100 and the National Institute of Health and Care
Excellence (NICE) guideline ‘Falls: assessment and prevention of
falls in older people’101 both are recommended.Table 1 – Domains of geriatric assessment resources.
Geriatric assessment domain
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a More information about measuring instruments can be found at ‘Try T
Geriatric Nursing: www.ConsultGeriRN.org.
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Quality of Life (QoL), although not formally part of the GA, is a
patient-reported outcome which complements the clinician's
evaluation of clinical progress and determination of clinical
benefits. The importance of maximizing functional status and
QoL throughout the course of disease and treatment in older
cancer population is growing.102 For older patients with cancer,
symptom burden and psychological distress caused by cancer
diagnosis and treatment in conjunction with pre-existing co-
morbid condition and geriatric syndromes cause profound
impact on QoL. While numerous factors including age, type
of chemotherapy, cancer site, symptom severity, and burden
of comorbidity have been shown to relate to QoL, the
findings are mixed.103,104 Previous cross-sectional studies
suggested an association between the symptom cluster, func-
tional status, and QoL in older patients with cancer receiving
cancer treatment.56,58
13.1. Advice for Nurses and Allied Health Care Professionals
Nurses and allied health care professionals can incorporate
QoL assessment into patient care and be proactive in providing
supportive care to older patients during their treatment trajecto-
ry. The European Organization for Research and Treatment of
Cancer (EORTC) QLQ-ELD 14105 is a geriatric-oncology specific QoL
instrument, which has been recently developed and validated toMeasuring instruments and guidelinesa
al Outcomes Social Support Survey (MOS-SS)11
fied Caregiver Strain Index (MCSI)106
son Comorbidity Index (CCI)14
lative Illness Rating Scale for Geriatrics (CIRS-G)107
n scale for instrumental activities of daily living (IADL)30
Index of Independence in Activities of Daily Living (ADL)29
COG36
Mental State Examination (MMSE)37
real Cognitive Assessment (MOCA)108
tric Depression Scale (GDS)42
utrition Screening Tool (MSTC)109
Nutritional Assessment (MNA)110
t-generated Subjective Global Assessment (PG-SGA)111 administered
titian if screening is positive
ional Assessment of Cancer Therapy: Fatigue (FACT-F)59
C QLQ C30 (Fatigue subscale)60
l Analogue Scale112
n bag method of medication reconciliation
Criteria67,74
ning Tool of Older Person's Prescriptions (STOPP)68,69,71
ation Appropriateness Index (MAI)70,72
S tool113
sion Assessment Method (CAM)90
orial Delirium Assessment Scale (MDAS)91
um Rating Scale-Revised 98 (DRS-R-98)92
um Observation Screening Scale (DOS)114
ican Geriatrics Society guideline100
nal Institute of Health and Care Excellence (NICE) guideline101
C-QLQ-ELD 14105
his® Assessment Tools’ on the website of the Hartford Institute for
t in daily oncology practice for nurses and allied health care
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Improvement in QoL may involve an effective management
of symptoms and psychological distress, and supportive care
and treatment in patients' co-morbid condition and geriatric
syndromes.14. Conclusion
Nurses and allied health care professionals have a crucial role
in the care of older persons with cancer through the CGA
process: identification of patients who can benefit from GA;
performance of the geriatric screening and GA; development
of geriatric recommendations for interventions; implementa-
tion of these recommendations in a care plan; and provision
of follow-up and adjustment of the care plan with repeated
CGA. A well-established follow-up increases the effectiveness
of the whole CGA-process.
The ability of nurses and allied health care professionals
to perform this particular assessment not only requires
specialized training and education beyond standard oncolo-
gy knowledge but also requires awareness for difficulties in
language/communication problems (e.g. immigrant popula-
tion) and health literacy in the older population. Knowledge
of the key domains to assess in an older person with cancer
can improve care by recognizing potential problems and
intervening early. Currently there is no evidence available to
define which time point is the most relevant to start the CGA
process. However, in oncology the CGA process is often
integrated when a treatment decision needs to be made.
Nurses and allied health care professionals need to be aware
of this particular time point to increase the level of
integration of CGA. Future research is needed to define the
ideal time point for CGA in older adults with cancer.
Additionally, a systematic review of each domain is war-
ranted in the oncology setting to further evaluate the best
evidence based practice.
This opinion paper revealed briefly specific background
information on the different key domains and the possible
measuring instruments which are summarized in Table 1.
Furthermore, organizational aspects should be reorganized
to allow nurses and allied health care professionals to
integrate this particular assessment in daily oncology practice
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